LinaTech is a domestic enterprise that has been deeply cultivating the radiotherapy field for thirty years. Since its founding, it has always regarded technological innovation as its lifeline, successfully establishing a complete industrial chain system from core component R&D to complete machine manufacturing, writing a new chapter of "Made in China" in the field of radiation therapy. Its core product, the medical linear accelerator, has broken the 20-year technical monopoly of European and American companies. With independently controllable core technology and independent intellectual property rights in both China and the United States, it has obtained market access certificates from 9 countries including NMPA and FDA, achieving a domestic production rate of over 95%. Super X, by integrating advanced technologies such as intelligent robotics, aims to overcome the world-class challenge of accurately aligning radiation beams with moving tumors. This breakthrough not only marks China's transition from a follower to a leader in the high-end radiotherapy equipment sector, but also sets new benchmarks for international radiotherapy standards—offering Chinese solutions to global cancer treatment.

Corporate Brochure